Table 1 Demographic and clinical characteristics
Number of patients (n) | 26 |
|---|---|
Age (years) | 51–78 |
Sex (male:female) | 12:14 |
Bilaterality (n) | 26 |
Extrapohthalmic involvement (n) | 21 |
steroid-sensitive patients (n) | 23 |
Auto-antibody (n) | 5 |
ANA | 4 |
SSA/SSB | 0 |
thyroid autoantibodies | 0 |
RF | 1 |
HLA | 0 |
Others | 0 |
Vision loss (n) | 26 |
Vision field defect (n) | 26 |
optic atrophy (n) | 10 |
papilledema (n) | 5 |